-9.92761e-13	RESULTS	6419	0.66993	0.59688	5795.27581
-4.93827e-13	EXAMINED	368	0.11748	0.12874	219.19992
-3.91687e-13	EXPRESSION	1332	0.31748	0.23537	1083.00470
-2.15605e-13	MUSCLES	37	0.01958	0.02731	7.74949
-1.32339e-13	TISSUES	152	0.04895	0.04291	30.44443
-1.21014e-13	DENDRITIC	34	0.01259	0.02081	3.79567
-1.07025e-13	MACROPHAGES	28	0.01259	0.02341	4.27013
-8.30447e-14	COMPARISON	158	0.07832	0.06372	72.32859
-5.75096e-14	LINES	65	0.07832	0.01691	19.18922
-2.46470e-14	SUBCUTANEOUS	16	0.01399	0.00390	0.79076
1.70974e-14	SKELETAL	74	0.04056	0.02861	16.81693
1.87073e-13	MUSCLE	157	0.08112	0.06762	79.49819
4.98379e-13	CELL	804	0.23916	0.15865	549.89763
7.53952e-13	PROGENITOR	20	0.01259	0.00910	1.66061
1.10922e-12	STEM	82	0.03077	0.07412	33.05396
1.26843e-12	OBESITY	22	0.01399	0.01430	2.89947
2.69429e-12	CARDIAC	19	0.00420	0.03511	2.13506
5.26645e-12	IMMUNE	32	0.01958	0.02471	7.01145
1.68729e-11	DCS	14	0.00979	0.00780	1.10707
4.49960e-10	MYOCARDIAL	10	0.00420	0.00910	0.55354
5.77114e-10	BRAIN	34	0.02098	0.03121	9.48917
8.92034e-10	LPS	18	0.01119	0.01691	2.74132
2.54524e-09	MORE	12	0.00979	0.00780	1.10707
3.47274e-09	DONORS	8	0.01818	0.00130	0.34266
3.98911e-09	PULMONARY	23	0.02657	0.01300	5.00818
4.71351e-09	HEMATOPOIETIC	21	0.02238	0.01300	4.21741
5.41865e-09	ADIPOCYTES	12	0.00699	0.01170	1.18615
1.70635e-08	GASTROCNEMIUS	11	0.00699	0.01040	1.05435
3.22116e-08	FIBROBLASTS	46	0.03217	0.03901	18.18758
3.52757e-08	REGIONS	15	0.00699	0.02341	2.37229
7.53283e-08	INHIBITOR	23	0.02238	0.01821	5.90437
9.39972e-08	LINE	38	0.05734	0.01691	14.04925
1.04073e-07	FEMALE	15	0.00979	0.01821	2.58316
6.64293e-07	BETWEEN	56	0.04615	0.04031	26.96507
7.89315e-07	TISSUE	67	0.05594	0.04291	34.79364
8.78982e-07	PROFILES	28	0.02657	0.02471	9.51553
1.35747e-06	HEART	14	0.00699	0.02731	2.76768
1.40432e-06	LEFT	9	0.00420	0.01691	1.02799
1.50861e-06	UNDERLYING	97	0.06014	0.06632	57.80489
1.77524e-06	PROFILING	290	0.14126	0.10663	218.30372
1.88063e-06	LYMPHOCYTES	8	0.02098	0.00260	0.79076
2.75111e-06	THAN	15	0.02238	0.01040	3.37393
5.15758e-06	WERE	15	0.02098	0.01170	3.55844
7.36931e-06	POPULATION	9	0.01119	0.00780	1.26522
1.12359e-05	48	27	0.03916	0.01821	10.33266
1.24361e-05	PREADIPOCYTES	7	0.00559	0.00910	0.73805
1.45227e-05	11	10	0.00839	0.01430	1.73968
2.29627e-05	KINASE	17	0.01119	0.03121	5.06089
2.38023e-05	DIFFERENTIATED	10	0.01399	0.00910	1.84512
2.76068e-05	MARROW	13	0.03357	0.00650	3.16306
3.21870e-05	CD8	6	0.00280	0.01430	0.57989
3.40624e-05	72	8	0.00699	0.01170	1.18615
3.56886e-05	MALE	38	0.01538	0.08192	18.26666
4.22231e-05	GENE	444	0.16783	0.15085	366.91473
5.18821e-05	DC	6	0.00420	0.01040	0.63261
6.48187e-05	DISTRIBUTION	6	0.00699	0.00650	0.65897
7.76604e-05	SP600125	3	0.00140	0.00390	0.07908
1.09198e-04	HSCS	4	0.00420	0.00390	0.23723
1.34712e-04	LIPOPOLYSACCHARIDE	8	0.00699	0.01430	1.44973
1.36422e-04	LUNGS	11	0.00559	0.03381	2.74132
1.54553e-04	WHILE	7	0.00839	0.00910	1.10707
1.61836e-04	DUCHENNE	9	0.01678	0.00780	1.89783
1.62992e-04	HSC	4	0.00699	0.00260	0.26359
1.80498e-04	JNK	3	0.00140	0.00520	0.10544
1.80498e-04	REJECTION	3	0.00559	0.00130	0.10544
1.80498e-04	UNDIFFERENTIATED	3	0.00559	0.00130	0.10544
1.83595e-04	OBESE	10	0.02098	0.00780	2.37229
1.92657e-04	SMALL	16	0.01818	0.02081	5.48263
2.19181e-04	DATA	5	0.01399	0.00260	0.52718
2.40906e-04	CULTURED	26	0.03916	0.02081	11.80875
3.05051e-04	DAY	25	0.00699	0.11183	11.33429
3.24161e-04	PLASMA	4	0.00839	0.00260	0.31631
3.24161e-04	UNIQUE	4	0.00839	0.00260	0.31631
3.45676e-04	YEAR	3	0.00699	0.00130	0.13179
3.99010e-04	OBTAINED	17	0.04895	0.00910	6.45791
5.00167e-04	HAIR	5	0.00420	0.01040	0.63261
7.99318e-04	12	32	0.03357	0.03511	17.08051
8.43822e-04	EXPRESS	7	0.01119	0.00910	1.47609
1.20111e-03	MRNA	8	0.01538	0.00910	2.02963
1.24173e-03	PROVIDE	3578	0.48811	0.48375	3422.11246
1.30034e-03	MOLECULAR	412	0.16783	0.14564	354.26250
1.33506e-03	KILLER	3	0.00280	0.00520	0.21087
1.33506e-03	SEX	3	0.00280	0.00520	0.21087
1.34160e-03	ATLAS	2	0.00280	0.00130	0.05272
1.34160e-03	ATRIAL	2	0.00280	0.00130	0.05272
1.34160e-03	CORNEAL	2	0.00140	0.00260	0.05272
1.34160e-03	PHYSIOLOGICALLY	2	0.00280	0.00130	0.05272
1.34160e-03	PROTEIN-ENCODING	2	0.00280	0.00130	0.05272
1.41163e-03	MUSCULAR	13	0.01958	0.01691	4.79730
1.53786e-03	PROVIDES	11	0.01399	0.01821	3.69023
2.11825e-03	INDUCIBLE	4	0.00699	0.00520	0.52718
2.15911e-03	ANTIGEN	6	0.00979	0.00910	1.29158
2.50768e-03	LINEAGE	3	0.00280	0.00650	0.26359
2.50863e-03	FAT	7	0.00559	0.02211	1.79240
2.93382e-03	B-CELL	5	0.01259	0.00520	0.94892
2.96632e-03	ERYTHROPOIESIS	2	0.00140	0.00390	0.07908
2.96632e-03	REVERSIBLE	2	0.00140	0.00390	0.07908
3.87141e-03	OLD	19	0.00979	0.06632	9.41010
4.04412e-03	KERATINOCYTES	4	0.01119	0.00390	0.63261
4.16775e-03	IFN	3	0.00559	0.00390	0.31631
4.16775e-03	NON-DIABETIC	3	0.01678	0.00130	0.31631
4.16775e-03	TRANSCRIPTOME	3	0.00420	0.00520	0.31631
4.41151e-03	MECHANISMS	204	0.09231	0.12614	168.74914
4.74509e-03	LUNG	45	0.05594	0.03641	29.52187
4.92236e-03	EMBRYONIC	39	0.01399	0.12224	24.77729
5.18232e-03	MESENCHYMAL	2	0.00280	0.00260	0.10544
5.18232e-03	NATURAL	2	0.00280	0.00260	0.10544
5.94508e-03	EVENTS	11	0.01119	0.02731	4.42828
6.36615e-03	INHIBITION	3	0.00280	0.00910	0.36902
6.90040e-03	CULTURES	4	0.00979	0.00520	0.73805
7.95773e-03	EOM	2	0.00140	0.00650	0.13179
7.95773e-03	EXTRAOCULAR	2	0.00140	0.00650	0.13179
7.95773e-03	IMMUNITY	2	0.00140	0.00650	0.13179
8.91181e-03	WEEK	8	0.00420	0.04681	2.84675
1.12620e-02	ADRENAL	2	0.00280	0.00390	0.15815
1.12620e-02	ALLOGRAFT	2	0.00420	0.00260	0.15815
1.12620e-02	FOUR	2	0.00420	0.00260	0.15815
1.13732e-02	INFLAMMATION	9	0.02378	0.01040	3.58480
1.15545e-02	PART	7	0.01818	0.00910	2.39865
1.25234e-02	FAILURE	3	0.00420	0.00780	0.47446
1.25234e-02	RECIPIENTS	3	0.00839	0.00390	0.47446
1.31462e-02	SPECIFIC	6	0.01119	0.01170	1.89783
1.65301e-02	ESTRADIOL	3	0.00559	0.00650	0.52718
1.65301e-02	VENTRICLES	3	0.00280	0.01300	0.52718
1.72475e-02	DIFFERENT	10	0.02657	0.01170	4.50736
1.76490e-02	MAJOR	6	0.00979	0.01430	2.02963
1.79099e-02	MALES	19	0.01538	0.04941	11.01799
1.80180e-02	ANIMALS	8	0.00140	0.15995	3.24213
1.87716e-02	DMD	3	0.00979	0.00390	0.55354
1.93405e-02	OVEREXPRESSED	2	0.00280	0.00520	0.21087
1.93405e-02	ROUND	2	0.00280	0.00520	0.21087
1.93405e-02	SURGICAL	2	0.00559	0.00260	0.21087
2.40595e-02	CONCENTRATIONS	2	0.00420	0.00390	0.23723
2.59356e-02	SURVIVAL	8	0.01538	0.01560	3.47936
2.60145e-02	ALI	1	0.00140	0.00130	0.02636
2.60145e-02	BREAKDOWN	1	0.00140	0.00130	0.02636
2.60145e-02	CENTER	1	0.00140	0.00130	0.02636
2.60145e-02	CHLORIDE	1	0.00140	0.00130	0.02636
2.60145e-02	EFFECTIVENESS	1	0.00140	0.00130	0.02636
2.60145e-02	ENDOMETRIUM	1	0.00140	0.00130	0.02636
2.60145e-02	OUTER	1	0.00140	0.00130	0.02636
2.60145e-02	PYRUVATE	1	0.00140	0.00130	0.02636
2.60145e-02	SCHWANN	1	0.00140	0.00130	0.02636
2.60145e-02	SHEATH	1	0.00140	0.00130	0.02636
2.60145e-02	SIMILARITIES	1	0.00140	0.00130	0.02636
2.60145e-02	SUPERIOR	1	0.00140	0.00130	0.02636
2.62493e-02	DIFFERENCES	11	0.01958	0.01951	5.53535
2.62493e-02	FETAL	11	0.01399	0.02731	5.53535
2.62493e-02	LIVER	11	0.00839	0.04551	5.53535
2.91966e-02	CYTOTOXIC	2	0.00699	0.00260	0.26359
2.91966e-02	MYOTUBES	2	0.00140	0.01300	0.26359
2.91966e-02	NO	2	0.00699	0.00260	0.26359
2.91966e-02	OBSTRUCTIVE	2	0.00699	0.00260	0.26359
2.91966e-02	SUSCEPTIBLE	2	0.00280	0.00650	0.26359
2.91966e-02	TRANSMEMBRANE	2	0.00280	0.00650	0.26359
2.93374e-02	PRIOR	3	0.00699	0.00650	0.65897
2.93374e-02	SHOW	3	0.00699	0.00650	0.65897
3.11407e-02	THESE	7	0.02238	0.00910	2.95219
3.40644e-02	DYSTROPHY	10	0.01678	0.02081	5.06089
3.55751e-02	ANTERIOR	3	0.00420	0.01170	0.71169
3.97929e-02	INDUCTION	11	0.01259	0.03251	5.93073
4.06265e-02	FOLLICLE	2	0.00280	0.00780	0.31631
4.06265e-02	LYMPHOID	2	0.00280	0.00780	0.31631
4.06265e-02	OCCUR	2	0.00420	0.00520	0.31631
4.06265e-02	TRAINING	2	0.00420	0.00520	0.31631
4.06265e-02	TYROSINE	2	0.00559	0.00390	0.31631
4.48990e-02	MATURE	4	0.01399	0.00650	1.31794
4.60992e-02	SUBPOPULATIONS	3	0.00839	0.00650	0.79076
4.97246e-02	AIRWAY	6	0.01538	0.01170	2.60952
5.04634e-02	INDIVIDUALS	4	0.03636	0.00260	1.37066
5.13522e-02	150	1	0.00140	0.00260	0.05272
5.13522e-02	BENEFICIAL	1	0.00280	0.00130	0.05272
5.13522e-02	BULGE	1	0.00280	0.00130	0.05272
5.13522e-02	CONDITIONED	1	0.00280	0.00130	0.05272
5.13522e-02	GASTROINTESTINAL	1	0.00140	0.00260	0.05272
5.13522e-02	HEMATOPOEITIC	1	0.00140	0.00260	0.05272
5.13522e-02	HYPOTHALAMUS	1	0.00140	0.00260	0.05272
5.13522e-02	IMMUNOSUPPRESSION	1	0.00280	0.00130	0.05272
5.13522e-02	MENSTRUAL	1	0.00280	0.00130	0.05272
5.13522e-02	METHYLTRANSFERASE	1	0.00280	0.00130	0.05272
5.13522e-02	MV	1	0.00140	0.00260	0.05272
5.13522e-02	NEUROGENESIS	1	0.00280	0.00130	0.05272
5.13522e-02	ONTO	1	0.00280	0.00130	0.05272
5.13522e-02	POLYSOMAL	1	0.00140	0.00260	0.05272
5.13522e-02	SECRETED	1	0.00280	0.00130	0.05272
5.13522e-02	SECRETORY	1	0.00140	0.00260	0.05272
5.13522e-02	TECS	1	0.00280	0.00130	0.05272
5.17033e-02	FEMALES	6	0.00699	0.02601	2.63588
5.18786e-02	BONE	27	0.04615	0.02861	19.13650
5.78677e-02	PRIMARY	31	0.06713	0.02341	22.77402
6.03159e-02	NEUROMUSCULAR	2	0.00420	0.00650	0.39538
6.03159e-02	PROMOTES	2	0.00420	0.00650	0.39538
6.16432e-02	PROGRESSION	11	0.03776	0.01170	6.40519
6.26684e-02	CYCLE	4	0.01119	0.00910	1.47609
6.66165e-02	COMPLEX	3	0.00699	0.00910	0.92256
6.74722e-02	METHYLATION	2	0.00559	0.00520	0.42174
7.60309e-02	AMPLIFICATION	1	0.00140	0.00390	0.07908
7.60309e-02	ARISE	1	0.00420	0.00130	0.07908
7.60309e-02	ETHANOL	1	0.00140	0.00390	0.07908
7.60309e-02	FOLLICLES	1	0.00140	0.00390	0.07908
7.60309e-02	GCS	1	0.00140	0.00390	0.07908
7.60309e-02	INDICATES	1	0.00420	0.00130	0.07908
7.60309e-02	NK	1	0.00420	0.00130	0.07908
7.60309e-02	ORGANIZATION	1	0.00420	0.00130	0.07908
7.60309e-02	SIGNIFICANT	1	0.00420	0.00130	0.07908
7.60309e-02	SRC	1	0.00140	0.00390	0.07908
7.60309e-02	THUS	1	0.00140	0.00390	0.07908
8.25572e-02	ARTERY	2	0.00839	0.00390	0.47446
8.25572e-02	SELF-RENEWAL	2	0.00280	0.01170	0.47446
8.73748e-02	BEFORE	4	0.01259	0.00910	1.66061
9.51810e-02	POOLED	4	0.01818	0.00650	1.71332
9.85520e-02	22	2	0.00559	0.00650	0.52718
9.85520e-02	ROLES	2	0.00559	0.00650	0.52718
9.92836e-02	INVOLVED	11	0.02657	0.01821	7.01145
1.00068e-01	23	1	0.00280	0.00260	0.10544
1.00068e-01	CONVENTIONAL	1	0.00140	0.00520	0.10544
1.00068e-01	HEALING	1	0.00280	0.00260	0.10544
1.00068e-01	INTERACTION	1	0.00280	0.00260	0.10544
1.00068e-01	INTRAEPITHELIAL	1	0.00280	0.00260	0.10544
1.00068e-01	ROOT	1	0.00140	0.00520	0.10544
1.00068e-01	TOGETHER	1	0.00559	0.00130	0.10544
1.00068e-01	TRANSPLANTATION	1	0.00559	0.00130	0.10544
1.00068e-01	UNTIL	1	0.00140	0.00520	0.10544
1.01005e-01	SIMILAR	3	0.00839	0.00910	1.10707
1.01219e-01	EACH	6	0.02098	0.01040	3.16306
1.01929e-01	ALSO	9	0.03217	0.01170	5.45628
1.06848e-01	DIFFER	2	0.00979	0.00390	0.55354
1.09527e-01	COMPARED	22	0.03357	0.03381	16.44790
1.15323e-01	ADIPOSE	2	0.00280	0.01430	0.57989
1.17515e-01	HYPOXIC	3	0.00699	0.01170	1.18615
1.18469e-01	GENES	126	0.09510	0.08192	112.92117
1.23479e-01	INTERACTIONS	1	0.00699	0.00130	0.13179
1.23479e-01	QUADRICEP	1	0.00699	0.00130	0.13179
1.26160e-01	EXPRESSED	6	0.01119	0.02081	3.37393
1.32750e-01	BASED	2	0.00559	0.00780	0.63261
1.32750e-01	FUNCTIONAL	2	0.00559	0.00780	0.63261
1.32750e-01	MM	2	0.00559	0.00780	0.63261
1.39647e-01	RESPONSES	6	0.01678	0.01430	3.47936
1.46281e-01	ALTERATIONS	1	0.00420	0.00260	0.15815
1.46281e-01	ANTIGENS	1	0.00280	0.00390	0.15815
1.46281e-01	CIRCADIAN	1	0.00140	0.00780	0.15815
1.46281e-01	C-KIT	1	0.00280	0.00390	0.15815
1.46281e-01	CORNEA	1	0.00140	0.00780	0.15815
1.46281e-01	CORONARY	1	0.00420	0.00260	0.15815
1.46281e-01	ESTABLISHED	1	0.00420	0.00260	0.15815
1.46281e-01	FEATURES	1	0.00420	0.00260	0.15815
1.46281e-01	INACTIVATION	1	0.00280	0.00390	0.15815
1.46281e-01	INDEPENDENT	1	0.00420	0.00260	0.15815
1.46281e-01	MEDIA	1	0.00420	0.00260	0.15815
1.46281e-01	PREGNANCY	1	0.00280	0.00390	0.15815
1.46281e-01	SUBJECT	1	0.00420	0.00260	0.15815
1.46281e-01	TERMINALLY	1	0.00420	0.00260	0.15815
1.46281e-01	VARIABILITY	1	0.00420	0.00260	0.15815
1.46281e-01	VENTRICULAR	1	0.00140	0.00780	0.15815
1.62033e-01	POTENTIAL	9	0.02937	0.01430	6.08889
1.65295e-01	CHRONIC	10	0.04615	0.01040	6.95873
1.68491e-01	DEFENSE	1	0.00140	0.00910	0.18451
1.69130e-01	25	2	0.00559	0.00910	0.73805
1.69130e-01	SUCH	2	0.00979	0.00520	0.73805
1.78639e-01	CONDITIONS	3	0.00699	0.01430	1.44973
1.87890e-01	MATERNAL	2	0.00420	0.01300	0.79076
1.87890e-01	WHOSE	2	0.00839	0.00650	0.79076
1.90122e-01	200	1	0.00559	0.00260	0.21087
1.90122e-01	ANTIVIRAL	1	0.00280	0.00520	0.21087
1.90122e-01	ERYTHROID	1	0.00280	0.00520	0.21087
1.90122e-01	EVALUATION	1	0.00559	0.00260	0.21087
1.90122e-01	LONG	1	0.00280	0.00520	0.21087
1.90122e-01	MATRIX	1	0.00280	0.00520	0.21087
1.90122e-01	RISK	1	0.00559	0.00260	0.21087
1.90122e-01	STRUCTURE	1	0.00280	0.00520	0.21087
1.90122e-01	THERAPEUTIC	1	0.00280	0.00520	0.21087
2.00128e-01	CANCER	27	0.14965	0.01040	22.56315
2.04633e-01	GENERATED	4	0.01119	0.01430	2.31958
2.11191e-01	17	1	0.00140	0.01170	0.23723
2.11191e-01	DIFFERENCE	1	0.00420	0.00390	0.23723
2.11191e-01	MICROARRAY	1	0.00420	0.00390	0.23723
2.11191e-01	SET	1	0.00420	0.00390	0.23723
2.11191e-01	SIGNALS	1	0.00420	0.00390	0.23723
2.11191e-01	TOLL-LIKE	1	0.00140	0.01170	0.23723
2.12823e-01	DIFFERENTIATE	5	0.02098	0.01040	3.16306
2.15496e-01	NUCLEAR	4	0.01259	0.01300	2.37229
2.17489e-01	INTERFERON	5	0.01538	0.01430	3.18942
2.20985e-01	HAS	4	0.00979	0.01691	2.39865
2.20985e-01	PRESENCE	4	0.01818	0.00910	2.39865
2.31712e-01	36	1	0.01399	0.00130	0.26359
2.31712e-01	ALONE	1	0.00280	0.00650	0.26359
2.31712e-01	ATROPHY	1	0.00280	0.00650	0.26359
2.31712e-01	TRANSLOCATION	1	0.00280	0.00650	0.26359
2.46447e-01	DURING	18	0.02937	0.03511	14.94545
2.48943e-01	18	4	0.00839	0.02081	2.53045
2.51616e-01	SIGNALING	13	0.02517	0.02861	10.43809
2.51699e-01	RELATIONSHIP	1	0.00140	0.01430	0.28995
2.53283e-01	16	3	0.00839	0.01430	1.73968
2.60769e-01	KIDNEY	5	0.01399	0.01691	3.42665
2.66721e-01	ACUTE	18	0.04476	0.02341	15.18268
2.71166e-01	COMBINATION	1	0.00559	0.00390	0.31631
2.71166e-01	FATE	1	0.00559	0.00390	0.31631
2.71166e-01	METHODS	1	0.00559	0.00390	0.31631
2.71166e-01	PHENOTYPE	1	0.00140	0.01560	0.31631
2.71166e-01	SIZE	1	0.00839	0.00260	0.31631
2.71166e-01	TIBIALIS	1	0.00280	0.00780	0.31631
2.71166e-01	VENTRICLE	1	0.00280	0.00780	0.31631
2.74539e-01	SPLEEN	2	0.00140	0.05072	1.02799
2.84227e-01	KEY	2	0.00559	0.01300	1.05435
2.95031e-01	SENSITIVITY	4	0.01818	0.01040	2.74132
2.95693e-01	RENAL	3	0.01678	0.00780	1.89783
3.01984e-01	AGE	8	0.01399	0.03121	6.32612
3.08594e-01	AGING	1	0.00280	0.00910	0.36902
3.08594e-01	BASAL	1	0.00979	0.00260	0.36902
3.08594e-01	EXHIBITING	1	0.00280	0.00910	0.36902
3.24209e-01	HEARTS	3	0.00559	0.02471	2.00327
3.26581e-01	BEEN	1	0.00420	0.00650	0.39538
3.26581e-01	INDIVIDUAL	1	0.02098	0.00130	0.39538
3.38475e-01	COLON	3	0.01818	0.00780	2.05599
3.44100e-01	DOMINANT	1	0.00280	0.01040	0.42174
3.44100e-01	PURIFIED	1	0.00559	0.00520	0.42174
3.48160e-01	DNA	8	0.02517	0.01821	6.64242
3.52721e-01	LEVELS	3	0.01399	0.01040	2.10871
3.60812e-01	COMBINED	2	0.01119	0.00780	1.26522
3.70196e-01	HIGHLY	2	0.00979	0.00910	1.29158
3.70196e-01	PROFILE	2	0.00979	0.00910	1.29158
3.77783e-01	ENRICHED	1	0.00280	0.01170	0.47446
3.77783e-01	LYMPHOMA	1	0.01259	0.00260	0.47446
3.77783e-01	PRODUCE	1	0.00280	0.01170	0.47446
3.77783e-01	SUBTYPES	1	0.01259	0.00260	0.47446
3.77783e-01	TAKEN	1	0.01259	0.00260	0.47446
3.79525e-01	CORTEX	2	0.00699	0.01300	1.31794
3.79525e-01	THEIR	2	0.01399	0.00650	1.31794
3.81080e-01	BETA	3	0.00979	0.01560	2.21414
3.83221e-01	DERIVED	16	0.04056	0.02471	14.52371
4.09736e-01	DEPRIVATION	1	0.00699	0.00520	0.52718
4.12752e-01	DEVELOPMENT	32	0.02098	0.10013	30.44443
4.19007e-01	HIGH	11	0.02657	0.02601	10.01635
4.20661e-01	EXPOSED	7	0.02517	0.01691	6.16796
4.25092e-01	CANDIDATE	1	0.00420	0.00910	0.55354
4.25220e-01	AGONIST	2	0.00699	0.01430	1.44973
4.34150e-01	13	2	0.00559	0.01821	1.47609
4.47470e-01	RESISTANT	4	0.01818	0.01300	3.42665
4.68805e-01	30	1	0.00420	0.01040	0.63261
4.68805e-01	DYSFUNCTION	1	0.00839	0.00520	0.63261
4.68805e-01	LARGE	1	0.00839	0.00520	0.63261
4.69092e-01	FIBROBLAST	2	0.01399	0.00780	1.58153
4.75938e-01	CRITICAL	4	0.01259	0.01951	3.55844
4.78663e-01	NORMAL	32	0.09790	0.02211	31.36699
4.83972e-01	PROTEINS	3	0.01259	0.01430	2.60952
4.90634e-01	DIFFERENTIATION	42	0.03497	0.08192	41.51514
4.91593e-01	PATIENTS	24	0.20839	0.00780	23.56478
4.92636e-01	ARE	122	0.10070	0.08322	121.46143
5.02708e-01	FIBROSIS	2	0.01119	0.01040	1.68696
5.09194e-01	MITOCHONDRIAL	1	0.00420	0.01170	0.71169
5.09194e-01	SIGNATURES	1	0.01259	0.00390	0.71169
5.14403e-01	AS	54	0.04336	0.08583	53.93014
5.22823e-01	TYPES	3	0.02937	0.00650	2.76768
5.23275e-01	HYPOXIA	5	0.01958	0.01691	4.79730
5.41708e-01	REGULATING	4	0.00979	0.02731	3.87475
5.42853e-01	INDUCE	9	0.01538	0.04031	8.98836
5.46512e-01	CYTOKINE	1	0.00699	0.00780	0.79076
5.46512e-01	INFLUENCE	1	0.00839	0.00650	0.79076
5.46512e-01	REQUIRED	1	0.00420	0.01300	0.79076
5.46512e-01	SURGERY	1	0.00839	0.00650	0.79076
5.50468e-01	HOUR	2	0.00979	0.01300	1.84512
5.65652e-01	FAMILY	2	0.00839	0.01560	1.89783
5.66035e-01	BREAST	3	0.07832	0.00260	2.95219
5.69801e-01	CYTOKINES	1	0.01119	0.00520	0.84348
5.69801e-01	HYPERTENSION	1	0.00559	0.01040	0.84348
5.83104e-01	WEEKS	4	0.00699	0.04031	4.08562
5.95385e-01	RESPECTIVELY	3	0.01259	0.01691	3.08398
6.00136e-01	DAYS	59	0.03217	0.13004	60.62528
6.01974e-01	DISEASES	2	0.01538	0.00910	2.02963
6.02511e-01	STATE	1	0.00979	0.00650	0.92256
6.12852e-01	CLINICAL	1	0.01678	0.00390	0.94892
6.22639e-01	MARKERS	2	0.02797	0.00520	2.10871
6.51595e-01	MACROPHAGE	1	0.01119	0.00650	1.05435
6.51595e-01	OTHER	1	0.00699	0.01040	1.05435
6.69488e-01	NG/ML	1	0.00839	0.00910	1.10707
6.69488e-01	OBSERVED	1	0.00979	0.00780	1.10707
6.69488e-01	SMOOTH	1	0.00839	0.00910	1.10707
6.73422e-01	AFTER	147	0.10909	0.09623	152.14309
6.80677e-01	SEVERAL	4	0.00559	0.05722	4.63915
6.80677e-01	SKIN	4	0.02238	0.01430	4.63915
6.86462e-01	GENETIC	1	0.00559	0.01430	1.15979
6.86462e-01	SEARCH	1	0.01538	0.00520	1.15979
6.86462e-01	VIRUS	1	0.01538	0.00520	1.15979
6.89861e-01	SUGGEST	3	0.02098	0.01170	3.55844
6.92197e-01	THAT	248	0.14126	0.12484	255.57509
7.12947e-01	FORMATION	3	0.00979	0.02601	3.69023
7.16310e-01	RNA	5	0.02657	0.01560	6.00981
7.16310e-01	STAGES	5	0.01678	0.02471	6.00981
7.18921e-01	INDICATE	2	0.01678	0.01040	2.53045
7.18921e-01	STIMULATED	2	0.01678	0.01040	2.53045
7.30441e-01	SYSTEM	3	0.01119	0.02341	3.79567
7.34477e-01	100	2	0.01259	0.01430	2.60952
7.36168e-01	INJURY	4	0.01399	0.02471	5.00818
7.43002e-01	PROLIFERATION	3	0.00979	0.02731	3.87475
7.56290e-01	VITRO	5	0.02238	0.01951	6.32612
7.58769e-01	MAMMARY	2	0.01119	0.01691	2.74132
7.59117e-01	CONTRIBUTE	1	0.01259	0.00780	1.42338
7.71489e-01	CONTAINING	1	0.00979	0.01040	1.47609
7.71489e-01	DISTINCT	1	0.01119	0.00910	1.47609
7.71489e-01	PLAY	1	0.01119	0.00910	1.47609
8.13080e-01	APOPTOSIS	2	0.01818	0.01170	3.08398
8.20392e-01	ESTROGEN	2	0.02378	0.00910	3.13670
8.25576e-01	VARIOUS	126	0.10490	0.08973	136.40688
8.27563e-01	TEMPORAL	18	0.02238	0.06762	21.93054
8.28045e-01	AN	89	0.08951	0.07542	97.84393
8.33458e-01	IMPLICATED	1	0.00559	0.02211	1.79240
8.37791e-01	PROSTATE	1	0.03217	0.00390	1.81876
8.38016e-01	EPITHELIAL	24	0.07273	0.02731	28.78383
8.41523e-01	UM	3	0.01538	0.02081	4.63915
8.50126e-01	CAN	1	0.01678	0.00780	1.89783
8.68896e-01	ISOLATED	5	0.02657	0.01951	7.51226
8.82934e-01	DIABETES	2	0.00979	0.02601	3.69023
8.88710e-01	TUMOR	17	0.08392	0.01821	22.14141
8.91794e-01	TRANSCRIPTIONAL	10	0.02657	0.03641	14.02289
8.92283e-01	IMPORTANT	2	0.01259	0.02081	3.79567
8.95005e-01	USING	11	0.04056	0.02601	15.28811
8.97405e-01	FUNCTION	13	0.02238	0.05462	17.71312
9.01703e-01	MULTIPLE	1	0.01538	0.01040	2.31958
9.01703e-01	REGULATED	1	0.01119	0.01430	2.31958
9.06752e-01	AFFECTED	1	0.01259	0.01300	2.37229
9.06752e-01	RESISTANCE	1	0.02098	0.00780	2.37229
9.20749e-01	THIS	6	0.02238	0.02991	9.70004
9.26448e-01	WHOLE	1	0.01259	0.01430	2.60952
9.29805e-01	REGULATION	3	0.02378	0.01691	5.82530
9.35531e-01	NOT	1	0.01119	0.01691	2.74132
9.41984e-01	BUT	1	0.01259	0.01560	2.84675
9.41984e-01	CARCINOMA	1	0.05035	0.00390	2.84675
9.47790e-01	STUDY	1	0.02238	0.00910	2.95219
9.47790e-01	TWO	1	0.02238	0.00910	2.95219
9.65553e-01	HAVE	4	0.02098	0.02731	8.30303
9.69186e-01	STIMULATION	1	0.01538	0.01560	3.47936
9.70553e-01	CAUSE	2	0.02378	0.01560	5.37720
9.70553e-01	SUBJECTED	2	0.01678	0.02211	5.37720
9.72270e-01	LOSS	1	0.01119	0.02211	3.58480
9.75964e-01	ADULT	3	0.01678	0.02991	7.27503
9.75964e-01	MAY	3	0.03217	0.01560	7.27503
9.79021e-01	ENDOTHELIAL	4	0.05315	0.01170	9.01472
9.79411e-01	INFECTED	2	0.02797	0.01430	5.79894
9.80164e-01	OVEREXPRESSING	4	0.02098	0.02991	9.09379
9.82545e-01	INTO	3666	0.50350	0.51756	3776.69126
9.83570e-01	NM	2	0.01399	0.02991	6.06253
9.83634e-01	LOW	1	0.01678	0.01691	4.11198
9.85328e-01	PATHWAYS	4	0.02657	0.02471	9.51553
9.87263e-01	WHICH	9	0.03217	0.03641	16.97508
9.87480e-01	INDUCES	3	0.01958	0.02861	8.11852
9.87480e-01	SYNDROME	3	0.03077	0.01821	8.11852
9.88686e-01	THOSE	1	0.02378	0.01300	4.48100
9.92969e-01	GROWTH	10	0.03217	0.04161	19.40009
9.93021e-01	ACID	3	0.02238	0.02731	8.85656
9.93666e-01	POSITIVE	1	0.02238	0.01560	5.06089
9.94147e-01	TARGETS	1	0.01818	0.01951	5.13997
9.94593e-01	BLOOD	1	0.09231	0.00390	5.21905
9.94593e-01	INFECTION	1	0.03077	0.01170	5.21905
9.94984e-01	USED	29	0.04476	0.06892	44.70455
9.95498e-01	BASIS	31	0.06294	0.05202	47.44587
9.96116e-01	MODEL	4	0.01538	0.05072	11.30793
9.96316e-01	PROTEIN	35	0.04755	0.07672	52.87579
9.96579e-01	EFFECT	17	0.05175	0.04031	30.23356
9.96651e-01	EXPOSURE	2	0.03217	0.01691	7.88129
9.97764e-01	INDUCED	33	0.03916	0.09103	51.66328
9.98243e-01	EXAMINATION	6	0.03776	0.02861	15.65714
9.98941e-01	CHANGES	6	0.03217	0.03511	16.36883
9.99378e-01	EITHER	1	0.02797	0.01821	7.38047
9.99469e-01	CONTROL	1	0.03077	0.01691	7.53862
9.99570e-01	PERIPHERAL	1	0.05874	0.00910	7.74949
9.99626e-01	TREATMENT	75	0.10769	0.06892	107.57033
9.99633e-01	BOTH	1	0.03497	0.01560	7.90765
9.99748e-01	ASSOCIATED	7	0.04615	0.02991	20.00634
9.99855e-01	CELLS	1975	0.47832	0.30689	2127.47282
9.99872e-01	MUTANT	1	0.01399	0.04421	8.96200
9.99895e-01	EARLY	5	0.02937	0.04161	17.71312
9.99909e-01	FOR	651	0.23916	0.21586	748.22137
9.99968e-01	PATHOGENESIS	28	0.09930	0.03771	54.27280
9.99971e-01	TRANSCRIPTION	9	0.02797	0.06502	26.35882
9.99976e-01	TREATED	94	0.10350	0.09233	138.48922
9.99986e-01	DISEASE	14	0.06713	0.03641	35.42625
9.99997e-01	HUMAN	1	0.04476	0.01951	12.65223
9.99999e-01	ROLE	126	0.08951	0.14304	185.56607